Stefan Loren

Dr. Stefan D.
Loren is a Managing Director at Oppenheimer & Co., Inc., an Independent Director at Cellectar Biosciences, Inc. and an Advisory Board at Prevail Partners LLC.
He is on the Board of Directors at Cellectar Biosciences, Inc. Dr. Loren was previously employed as a Co-Founder by Loren Capital Strategy LLC, a Board by Marina Biotech, Inc., a Board Director by GenVec, Inc., a Lead Independent Director by Marina Biotech, Inc., a Board Member by Orchid Cellmark, Inc., an Alumni Board Director by University of California San Diego, a Managing Director by Westwicke Partners LLC, an Independent Director by PolyMedix, Inc., an Analyst by Perceptive Advisors LLC, a Managing Director-Healthcare Group by Legg Mason, Inc., a Research Chemist-Advanced Technologies Division by Abbott Laboratories, a Managing Director by Legg Mason Wood Walker, Inc., a Portfolio Manager by MTB Investment Advisors, Inc., and an Advisor by Numoda Capital Innovations LLC.
He also served on the board at Orchid Cellmark, Inc. He received his undergraduate degree from the University of California San Diego and a doctorate degree from the University of California, Berkeley.